化学信息:
化学名 | N-methyl-N-[3-[3-(thiophene-2-carbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide | |
简称 | Indiplon | |
别名 |
NBI 34060, NBI-34060, NBI34060 |
|
中文名 | 茚地普隆 | |
化学式 | C20H16N4O2S | |
分子量 | 376.43 | |
CAS号 | 325715-02-4 | |
纯度 | 98% | |
溶剂/溶解度 |
Water<1mg/ml; DMSO4mg/ml; Ethanol<1mg/ml |
|
溶液配制 | 5mg加入1.33ml DMSO,或者每3.76mg加入1ml DMSO,配制成10mM溶液。SF9002-10mM用DMSO配制。 |
生物信息:
产品描述 | Indiplon is a potent GABAA receptor positive allosteric modulator that acts at the benzodiazepine site (Ki values are 1.2 and 1.7nM in rat frontal cortex and cerebellum respectively). | ||||
信号通路 | Transmembrane Transporters | ||||
靶点 | GABAA receptor | - | - | - | - |
IC50 | - | - | - | - | - |
体外研究 | Indiplon displays ~ 10-fold selectivity for α1 subunit-containing receptors (EC50 values are 2.6, 24, 60 and 77nM for α1β2γ2, α2β2γ2, α3β3γ2 andα5β2γ2 receptors respectively). | ||||
体内研究 | Indiplon exhibits sedative, hypnotic, anxiolytic and anticonvulsant activity and is orally active. Indiplon is a novel sedative-hypnotic recently approved for the treatment of insomnia. Indiplon is a novel sedative-hypnotic that modulates subunits of the GABA receptor complex in order to induce sedation. Indiplon shows a higher affinity and selectivity to GABAA receptors. | ||||
临床实验 | N/A | ||||
特征 | N/A |
相关实验数据(此数据来自于公开文献,碧云天并不保证其有效性):
酶活性检测实验 | |
方法 | N/A |
细胞实验 | |
细胞系 | N/A |
浓度 | N/A |
处理时间 | N/A |
方法 | N/A |
动物实验 | |
动物模型 | N/A |
配制 | N/A |
剂量 | N/A |
给药方式 | N/A |
产品编号 | 产品名称 | 包装 |
SF9002-10mM | Indiplon (GABA Receptor调节剂) | 10mM×0.2ml |
SF9002-5mg | Indiplon (GABA Receptor调节剂) | 5mg |
SF9002-25mg | Indiplon (GABA Receptor调节剂) | 25mg |
— | 说明书 | 1份 |
保存条件:
-20℃保存,至少一年有效。5mg和25mg包装也可室温保存,至少6个月有效。如果溶于非DMSO溶剂,建议分装后-80℃保存,预计6个月内有效。